GS
The Goldman Sachs Group, Inc.
GS's fundamentals are strong: revenue grew 19% and its operating margin rose 4 points to 40%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
MRX
Marex Group plc Ordinary Shares
There isn't enough reported data to score MRX yet.
GS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
GS's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like GS.
MRX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| N/A | |
| N/A |
There isn't enough reported data to rate MRX's fundamentals.
GS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.6x | $528 | -42% |
| Current | 13x | $914 | — |
| Forward | 13x | $914 | — |
| Fair | 14x | $940 | +2.9% |
| Expensive | 17x | $1,214 | +33% |
Historical ranges are pointers, not guarantees.
GS's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
MRX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 12x | N/A | N/A |
| Fair | 14x | N/A | N/A |
| Expensive | 17x | N/A | N/A |
| Current | 18x | $71.68 | — |
Historical ranges are pointers, not guarantees.
MRX's PE is 18x, but its earnings don't support one, so it isn't a reliable read right now.
GS Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for GS, with profitability improving. However, they disagree widely on these estimates.
MRX Forward outlook
There aren't enough analyst estimates for MRX to show an outlook.
GS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $72.35 | +4% |
| Q3 2026 | $69.58 | +41% |
| Q2 2026 | $64.82 | +43% |
| Q1 2026 | $54.75 | +27% |
| Q4 2025 | $51.32 | +27% |
| Q3 2025 | $49.22 | +44% |
| Q2 2025 | $45.37 | +45% |
| Q1 2025 | $43.08 | +68% |
| Q4 2024 | $40.54 | +77% |
GS's earnings per share have climbed steadily: $69.58 over the past year, up 41% from the year before, and higher year over year for 10 quarters in a row. Its recent earnings include one-off gains.
MRX Earnings Per Share
MRX and GS do not have enough comparable growth data to identify a winner.
GS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $18.7B | +23% |
| Q2 2026 | $20.3B | +39% |
| Q1 2026 | $17.2B | +14% |
| Q4 2025 | $13.5B | -3% |
| Q3 2025 | $15.2B | +20% |
| Q2 2025 | $14.6B | +15% |
| Q1 2025 | $15.1B | +6% |
| Q4 2024 | $13.9B | +23% |
GS's revenue is growing: $18.7B last quarter, up 23% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 37% | +2 points |
| Q2 2026 | 42% | +8.1 points |
| Q1 2026 | 38% | +0.2 points |
| Q4 2025 | 44% | +5.6 points |
| Q3 2025 | 36% | +4.1 points |
| Q2 2025 | 34% | +3.2 points |
| Q1 2025 | 37% | +0.6 points |
| Q4 2024 | 38% | +18 points |
GS's operating margin was 37% last quarter, up 2 points from the same quarter a year ago.
MRX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $2B | +306% |
| Q4 2025 | $3.1B | +45% |
| Q2 2025 | $500.1M | -32% |
| Q4 2024 | $2.2B | +199% |
| Q2 2024 | $740M | -36% |
| Q4 2023 | $720.7M | +109% |
| Q2 2023 | $1.2B | +75% |
| Q4 2022 | $345.3M | -16% |
MRX has the edge over GS in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 59% | +6.1 points |
| Q4 2025 | 34% | +50 points |
| Q2 2025 | 20% | +19 points |
| Q4 2024 | 20% | +2.2 points |
| Q2 2024 | 53% | +47 points |
| Q4 2023 | -16% | -25 points |
| Q2 2023 | 0.8% | -7.5 points |
| Q4 2022 | 18% | +13 points |
MRX has the edge over GS on profitability, with a higher operating margin.
GS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +72% |
| Q2 2026 | $5.6B | +7.8% |
| Q1 2026 | -$32.4B | +$5.3B |
| Q4 2025 | -$16.8B | -136% |
| Q3 2025 | $2.1B | +$40.6B |
| Q2 2025 | $5.2B | -6.8% |
| Q1 2025 | -$37.7B | -$9.2B |
| Q4 2024 | $46.2B | +$75.1B |
GS's free cash flow was −$40B over the past year, against $15.8B the year before. Free cash flow isn't a meaningful measure for financial services companies like GS.
MRX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $692M | -25% |
| Q4 2025 | -$264.5M | -138% |
| Q2 2025 | $918.9M | +107% |
| Q4 2024 | $704.6M | +95% |
| Q2 2024 | $443.3M | +23% |
| Q4 2023 | $361.5M | +234% |
| Q2 2023 | $361.5M | +234% |
| Q4 2022 | $108.1M | -53% |
MRX's free cash flow was $2.1B over the past year, up 61% from the year before. Free cash flow isn't a meaningful measure for financial services companies like MRX.
GS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -3.8M shares |
| 1 year | -4.4% | -13.9M shares |
| 3 years | -12% | -42.8M shares |
| 5 years | -15% | -52.8M shares |
| Available history | -20% | -74.4M shares |
GS has the edge over MRX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3B |
| Q2 2026 | $4B |
| Q1 2026 | $5B |
| Q4 2025 | $3B |
| Q3 2025 | $2B |
| Q2 2025 | $3B |
| Q1 2025 | $4.4B |
| Q4 2024 | $2B |
GS spent $15B buying back its own shares over the past year, up 32% from the year before.
MRX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -487K shares |
| 1 year | +4.7% | +3.4M shares |
| 3 years | +25% | +15M shares |
MRX has 76M diluted shares, up 4.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $125.6M |
| Q4 2025 | $200,000 |
| Q2 2025 | — |
| Q4 2024 | — |
| Q2 2024 | $19.8M |
| Q4 2023 | $1.6M |
| Q2 2023 | $1.6M |
| Q4 2022 | $4M |
GS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -5.4x | Net Cash |
| Q2 2026 | -6.1x | Net Cash |
| Q1 2026 | -6.7x | Net Cash |
| Q4 2025 | -6.4x | Net Cash |
| Q3 2025 | -3.5x | Net Cash |
| Q2 2025 | -3.1x | Net Cash |
| Q1 2025 | -3.9x | Net Cash |
| Q4 2024 | -4.7x | Net Cash |
GS has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like GS.
MRX Net Leverage
GS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.5 | Neutral |
| Stochastic | 16.3 | Oversold |
GS's weekly RSI is 45 (neutral) and its Stochastic is 16 (oversold).
MRX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.8 | Neutral |
| Stochastic | 40.9 | Neutral |
MRX's weekly RSI is 59 (neutral) and its Stochastic is 41 (neutral).
GS PE vs Financial Services Sector
| Metric | GS | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 0.8% above |
| PE % | 46 | 63 | 17 pts below |
GS has the edge over MRX on valuation relative to its sector.
MRX PE vs Financial Services Sector
| Metric | MRX | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 13x | 42% above |
| PE % | 93 | 29 | 64 pts above |
MRX is trading at 18x earnings, a 42% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
GS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $895.5 | 2% above |
| 20 week MA | $977.4 | 6.5% below |
| 50 week MA | $945.4 | 3.4% below |
| 100 week MA | $804.5 | 14% above |
| 200 week MA | $602.7 | 52% above |
MRX has stronger trend alignment. GS is above 3 of 5 weekly averages versus MRX above 4 of 4.
MRX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $69.8 | 2.6% above |
| 20 week MA | $69.1 | 3.8% above |
| 50 week MA | $55.3 | 30% above |
| 100 week MA | $45.7 | 57% above |
MRX is in an uptrend: it's above all four of its weekly moving averages, and 57% above its 100-week average.
GS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $230.7 | $256.2 | +11% |
| 2021 | $256.2 | $385.0 | +50% |
| 2022 | $385.0 | $345.5 | -10% |
| 2023 | $345.5 | $385.8 | +12% |
| 2024 | $385.8 | $576.2 | +49% |
| 2025 | $576.2 | $907.0 | +57% |
| 2026 YTD | $907.0 | $913.6 | +0.7% |
GS has finished higher in five of the last six years, two of them by more than 50%. It's up 0.7% so far in 2026.
MRX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $19.0 | $31.9 | +68% |
| 2025 | $31.9 | $39.6 | +24% |
| 2026 YTD | $39.6 | $71.7 | +81% |
MRX has the edge over GS on returns for 2026, with the stronger performance.